Back to medications
Medication monograph

rituximab

Monoclonal AntibodiesAnti-CD20 AntibodiesImmunosuppressantsCD20-directed Cytolytic AntibodyDisease-modifying Antirheumatic Drugs

Clinical reference

Product monograph

RUXIENCE- rituximab-pvvr injection, solution

Brands & formulations

Family members

RITUXAN

Marketed
10 MGINTRAVENOUSSOLUTION[ "rituximab" ]
Product monograph

RITUXAN SC

Marketed
1400 MGSUBCUTANEOUSSOLUTION[ "rituximab" ]
Product monograph

RITUXAN SC

Marketed
1600 MGSUBCUTANEOUSSOLUTION[ "rituximab" ]
Product monograph

TRUXIMA

Marketed
100 MGINTRAVENOUSSOLUTION[ "rituximab" ]
Product monograph

TRUXIMA

Marketed
500 MGINTRAVENOUSSOLUTION[ "rituximab" ]
Product monograph

RUXIENCE

Marketed
10 MGINTRAVENOUSSOLUTION[ "rituximab" ]
Product monograph

RIXIMYO

Marketed
10 MGINTRAVENOUSSOLUTION[ "rituximab" ]
Product monograph

Classification

Chemical class
Monoclonal Antibodies, Anti-CD20 Antibodies
Clinical class
Immunosuppressants
Banks class
CD20-directed Cytolytic Antibody
AHFS family
Disease-modifying Antirheumatic Drugs